Blood Disorders And Treatments

2 researchers across 1 institution

2 Researchers
1 Institutions
0 Grant PIs
0 High Impact

Research in blood disorders and treatments examines the causes, mechanisms, and therapies for a range of hematological conditions. This area investigates both benign and malignant blood disorders, including anemias, clotting disorders, and leukemias. Studies employ molecular and cellular biology techniques to understand disease pathogenesis, identify therapeutic targets, and develop novel treatment strategies. Investigations also explore the complexities of blood cell development, function, and regulation, with a focus on improving patient outcomes through innovative medical interventions.

This research is relevant to Arkansas's public health landscape, addressing the prevalence and impact of blood-related diseases within the state's population. Understanding and treating these conditions can lead to improved healthcare services and outcomes for Arkansans. Furthermore, advancements in this field can contribute to the state's growing biomedical sector, fostering innovation and economic development.

This research area draws upon expertise in molecular biology, immunology, and clinical medicine. Connections exist with fields such as hematopoietic stem cell transplantation, immune response and inflammation, and healthcare policy and management, reflecting a broad engagement across institutions focused on advancing blood disorder research and patient care.

AI-generated overview
Filter by institution:
Filter by career stage:

Top Researchers

Name Institution h-index Citations Career Stage Badges
Lauren A. Johnson UAMS 7 154 Faculty
V. Rakesh Sethapati UAMS 1 3 Faculty

Strategic Outlook

Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: HIGH

Global trajectory
2,274 works in 2026
-0.7% CAGR 2018–2026
Leadership concentration
7.1% held by global top 5 institutions
Fragmented HHI 31
Arkansas position
Arkansas not in global top 100
No AR institution among the top-100 contributors to this topic over the 2018–2026 window.

Top US institutions in this area

  1. 1 National Institutes of Health 1,725
  2. 2 Harvard University 1,266
  3. 3 University of Washington 1,008
  4. 4 Boston Children's Hospital 742
  5. 5 National Institute of Allergy and Infectious Diseases 631
Browse All 2 Researchers in Directory